☆ 4.7 Article

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

ANNALS OF ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Phase 3 THOR study: Results of erdafitinib (erda) versus chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select fibroblast growth factor receptor alterations (FGFRalt).

Yohann Loriot et al.

JOURNAL OF CLINICAL ONCOLOGY (2023)

添加到收藏夹

Review Oncology

Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs

Kristin Grabe-Heyne et al.

Summary: Bladder cancer is a common global cancer, with high recurrence and progression rates in intermediate- and high-risk non-muscle-invasive bladder cancer patients. Treatment challenges include inadequate adherence to guidelines, low patient compliance, and limited evidence for treatment effectiveness and safety. Efforts are needed to address these unmet treatment needs.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Arlene O. Siefker-Radtke et al.

Summary: This study evaluated the long-term efficacy and safety of Erdafitinib in patients with locally advanced or metastatic urothelial carcinoma. The results showed consistent activity and manageable safety profile in these patients.

LANCET ONCOLOGY (2022)

添加到收藏夹

Review Urology & Nephrology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Marko Babjuk et al.

Summary: The updated EAU guidelines provide new information on the diagnosis and treatment of NMIBC for clinical practice. Individual risk assessment is crucial in determining the appropriate treatment for patients with different risk levels. Surgical intervention, including radical cystectomy, may be necessary for cases unresponsive to BCG treatment or with high risk of progression.

EUROPEAN UROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guerin Immunotherapy

Roman Mayr et al.

Summary: This study investigated the relationship between fibroblast growth factor receptor alterations (FGFRa) and clinical outcomes in patients with non-muscle-invasive bladder cancer (NMIBC). The results showed that FGFRa were frequently observed in high-risk NMIBC patients, but there was no significant difference in outcomes between patients with FGFRa and those without FGFRa in BCG treatment.

EUROPEAN UROLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer A Randomized Clinical Trial

James W. F. Catto et al.

Summary: This study compared the recovery and morbidity of patients undergoing robot-assisted radical cystectomy with intracorporeal reconstruction versus open radical cystectomy for bladder cancer. The results showed that robot-assisted surgery resulted in a statistically significant increase in the number of days alive and out of the hospital within 90 days of surgery. In addition, robot-assisted surgery had lower rates of thromboembolic and wound complications compared to open surgery. Patients who underwent robot-assisted surgery also reported better quality of life and less disability compared to those who underwent open surgery.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification

Ivonne A. Montes-Mojarro et al.

Summary: This study aims to develop a multiparametric classification to distinguish low-grade and high-grade urothelial tumors by analyzing immunohistochemical stains and pathogenic mutations. Analysis of clinical and histological data revealed that PUN-LMP and LG-PUC belong to one cluster, while HG-PUC belongs to another cluster, providing guidance for clinical management.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Urology & Nephrology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

J. Alfred Witjes et al.

Summary: This article presents the updated European Association of Urology guidelines for muscle-invasive and metastatic bladder cancer, providing practical evidence-based recommendations and consensus statements on clinical management. The guidelines cover a broad scope and incorporate the latest research findings and results from consensus meetings.

EUROPEAN UROLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes

James W. F. Catto et al.

Summary: This study investigated the health-related quality of life following treatment for bladder cancer, revealing that most participants experienced problems in generic HRQOL, with age and long-term conditions affecting HRQOL. Sexual problems were commonly reported in men, especially in younger age groups and those who received radical treatment.

EUROPEAN UROLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial NIMBUS

Marc-Oliver Grimm et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Article Pathology

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma

Marie-Lisa Eich et al.

MODERN PATHOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Y. Loriot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Oncology

Recovering from Cystectomy: Patient Perspectives

Carmit K. McMullen et al.

BLADDER CANCER (2019)

添加到收藏夹

Article Urology & Nephrology

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

Eugene J. Pietzak et al.

EUROPEAN UROLOGY (2017)

添加到收藏夹

Article Oncology

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor

Timothy P. S. Perera et al.

MOLECULAR CANCER THERAPEUTICS (2017)

添加到收藏夹

Review Urology & Nephrology

BCG-unresponsive non-muscle invasive bladder cancer: recommendations from the IBCG

Ashish M. Kamat et al.

NATURE REVIEWS UROLOGY (2017)

添加到收藏夹

Article Urology & Nephrology

Prognostic impact of Bacillus Calmette-Guerin interruption at the time of induction and consolidation

M. Mofarej Alhogbani et al.

UROLOGY ANNALS (2017)

添加到收藏夹

Article Urology & Nephrology

Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?

Vincenzo Serretta et al.

UROLOGIA INTERNATIONALIS (2016)

添加到收藏夹

Review Oncology

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

Margaret A. Knowles et al.

NATURE REVIEWS CANCER (2015)

添加到收藏夹

Article Oncology

Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Raffaele Addeo et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Urology & Nephrology

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials

RJ Sylvester et al.

EUROPEAN UROLOGY (2006)

添加到收藏夹

Article Pathology

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

C Billerey et al.

AMERICAN JOURNAL OF PATHOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.